摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

溴化铜 | 7789-45-9

中文名称
溴化铜
中文别名
二溴化铜;二溴化铜(II)
英文名称
copper(II)bromide
英文别名
CuBr2;cupric bromide;Einecs 234-375-9;copper;dibromide
溴化铜化学式
CAS
7789-45-9
化学式
Br2Cu
mdl
——
分子量
223.354
InChiKey
QTMDXZNDVAMKGV-UHFFFAOYSA-L
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    498 °C(lit.)
  • 沸点:
    900 °C
  • 密度:
    4.77 g/mL at 25 °C(lit.)
  • 闪点:
    900°C
  • 溶解度:
    1200g/l
  • 暴露限值:
    ACGIH: TWA 1 mg/m3NIOSH: IDLH 100 mg/m3; TWA 1 mg/m3
  • 物理描述:
    Copper(ii) bromide is an odorless black solid. Sinks and mixes with water. (USCG, 1999)
  • 颜色/状态:
    Almost black, iodine like, monoclinic crystals or crystalline powder
  • 分解:
    WHEN STRONGLY HEATED, THEY EMIT HIGHLY TOXIC FUMES OF /HYDROGEN BROMIDE/. /BROMIDES/

计算性质

  • 辛醇/水分配系数(LogP):
    1.69
  • 重原子数:
    3
  • 可旋转键数:
    0
  • 环数:
    0.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

ADMET

代谢
主要通过消化道吸收,但也可以通过吸入和皮肤吸收。它通过基底外侧膜,可能是通过调节转运蛋白,并与血清白蛋白结合被运输到肝脏和肾脏。肝脏是稳态的关键器官。在肝脏和其他组织中,以与蛋白、氨基酸结合以及与依赖的酶相关联的形式储存,然后分配通过胆汁排出或并入细胞内和细胞外蛋白中。通过血浆中与血清白蛋白蓝蛋白或低分子量复合物结合被运输到外周组织。可能诱导蛋白和蓝蛋白的产生。膜结合的转运腺苷三磷酸酶(Cu-ATPase)将离子输送到细胞内和细胞外。体内生理正常平的通过改变的吸收速率和数量、分布区域以及排泄来保持恒定。主要通过吸入吸收,但也可以通过皮肤接触进入人体。盐可以摄入。由于的反应性,它迅速形成化物并可能沉积在组织中,取代其他卤素。(L626, L277, L279)
Copper is mainly absorbed through the gastrointestinal tract, but it can also be inhalated and absorbed dermally. It passes through the basolateral membrane, possibly via regulatory copper transporters, and is transported to the liver and kidney bound to serum albumin. The liver is the critical organ for copper homoeostasis. In the liver and other tissues, copper is stored bound to metallothionein, amino acids, and in association with copper-dependent enzymes, then partitioned for excretion through the bile or incorporation into intra- and extracellular proteins. The transport of copper to the peripheral tissues is accomplished through the plasma attached to serum albumin, ceruloplasmin or low-molecular-weight complexes. Copper may induce the production of metallothionein and ceruloplasmin. The membrane-bound copper transporting adenosine triphosphatase (Cu-ATPase) transports copper ions into and out of cells. Physiologically normal levels of copper in the body are held constant by alterations in the rate and amount of copper absorption, compartmental distribution, and excretion. Bromine is mainly absorbed via inhalation, but may also enter the body through dermal contact. Bromine salts can be ingested. Due to its reactivity, bromine quickly forms bromide and may be deposited in the tissues, displacing other halogens. (L626, L277, L279)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 毒性总结
过量的被隔离在肝细胞溶酶体内,在那里它与蛋白结合。当溶酶体饱和,在细胞核内积累,导致核损伤时,的肝脏毒性被认为会发生。这种损伤可能是由于氧化损伤,包括脂质过氧化。抑制了保护细胞免受自由基侵害的巯基酶,如葡萄糖-6-磷酸-1-脱氢酶、谷胱甘肽还原酶和过氧化物酶,它还影响基因表达,并且是氧化酶如细胞色素C氧化酶和赖氧化酶的辅因子。此外,由诱导的氧化应激被认为会激活酸性鞘磷脂酶,导致神经酰胺的产生,这是一种凋亡信号,也会引起溶血性贫血。引起的呕吐是由于迷走神经的刺激。是一种强氧化剂,能够从粘膜的分中释放氧自由基。这些自由基也是强大的氧化剂,会产生组织损伤。此外,氢溴酸溴酸的形成将导致二次刺激。溴离子还知道会影响中枢神经系统,导致中毒。这被认为是溴离子在神经递质和传输系统的反应中替代氯离子的结果,从而影响许多突触过程。(L626,L627,A543,L277,T49,A174,L280)
Excess copper is sequestered within hepatocyte lysosomes, where it is complexed with metallothionein. Copper hepatotoxicity is believed to occur when the lysosomes become saturated and copper accumulates in the nucleus, causing nuclear damage. This damage is possibly a result of oxidative damage, including lipid peroxidation. Copper inhibits the sulfhydryl group enzymes such as glucose-6-phosphate 1-dehydrogenase, glutathione reductase, and paraoxonases, which protect the cell from free oxygen radicals. It also influences gene expression and is a co-factor for oxidative enzymes such as cytochrome C oxidase and lysyl oxidase. In addition, the oxidative stress induced by copper is thought to activate acid sphingomyelinase, which lead to the production of ceramide, an apoptotic signal, as well as cause hemolytic anemia. Copper-induced emesis results from stimulation of the vagus nerve. Bromine is a powerful oxidizing agent and is able to release oxygen free radicals from the water in mucous membranes. These free radicals are also potent oxidizers and produce tissue damage. In additon, the formation of hydrobromic and bromic acids will result in secondary irritation. The bromide ion is also known to affect the central nervous system, causing bromism. This is believed to be a result of bromide ions substituting for chloride ions in the in actions of neurotransmitters and transport systems, thus affecting numerous synaptic processes. (L626, L627, A543, L277, T49, A174, L280)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 致癌物分类
对人类无致癌性(未列入国际癌症研究机构IARC清单)。
No indication of carcinogenicity to humans (not listed by IARC).
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 健康影响
人们每天必须吸收少量,因为对健康至关重要。然而,高平的可能有害。极高剂量的会损害肝脏和肾脏,甚至可能致命。可能在敏感个体中引发过敏反应。蒸汽会引起刺激和直接损害粘膜。元素也会烧伤皮肤。化物离子是一种中枢神经系统抑制剂,长期暴露会产生神经元效应。这被称为中毒,可能导致从嗜睡到昏迷、恶病质、昏迷、反射丧失或病理反射、阵挛性惊厥、震颤、共济失调、神经敏感性丧失、麻痹、眼乳头肿、语言异常、脑肿、谵妄、攻击性和精神病的中心反应。(L625, L626, L627, L278, L279)
People must absorb small amounts of copper every day because copper is essential for good health, however, high levels of copper can be harmful. Very-high doses of copper can cause damage to your liver and kidneys, and can even cause death. Copper may induce allergic responses in sensitive individuals. Bromine vapour causes irritation and direct damage to the mucous membranes. Elemental bromine also burns the skin. The bromide ion is a central nervous system depressant and chronic exposure produces neuronal effects. This is called bromism and can result in central reactions reaching from somnolence to coma, cachexia, exicosis, loss of reflexes or pathologic reflexes, clonic seizures, tremor, ataxia, loss of neural sensitivity, paresis, papillar edema of the eyes, abnormal speech, cerebral edema, delirium, aggressiveness, and psychoses. (L625, L626, L627, L278, L279)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 暴露途径
口服 (L277) ; 吸入 (L277) ; 皮肤给药 (L277)
Oral (L277) ; inhalation (L277) ; dermal (L277)
来源:Toxin and Toxin Target Database (T3DB)
毒理性
  • 症状
吸入高浓度的可以导致鼻和喉咙的刺激。摄入高浓度的可以引起恶心、呕吐、腹泻、头痛、眩晕和呼吸困难。蒸气会引起刺激和对粘膜的直接损害。症状包括流泪、流鼻涕、眼部刺激伴有来自口咽和上呼吸道的粘液分泌、咳嗽、呼吸困难、窒息、喘息、鼻出血和头痛。化物离子是一种中枢神经系统抑制剂,会引起共济失调、言语不清、震颤、恶心、呕吐、乏力、眩晕、视觉障碍、不稳定、头痛、记忆和注意力受损、定向障碍和幻觉。这被称为中毒。
Breathing high levels of copper can cause irritation of the nose and throat. Ingesting high levels of copper can cause nausea, vomiting, diarrhea, headache, dizziness, and respiratory difficulty. Bromine vapour causes irritation and direct damage to the mucous membranes. Symptoms include lacrimation, rhinorrhoea, eye irritation with mucous secretions from the oropharyngeal and upper airways, coughing, dyspnoea, choking, wheezing, epistaxis, and headache. The bromide ion is a central nervous system depressant producing ataxia, slurred speech, tremor, nausea, vomiting, lethargy, dizziness, visual disturbances, unsteadiness, headaches, impaired memory and concentration, disorientation and hallucinations. This is called bromism. (L626, L627, L278, L279)
来源:Toxin and Toxin Target Database (T3DB)

安全信息

  • TSCA:
    Yes
  • 危险等级:
    8
  • 危险品标志:
    Xi
  • 安全说明:
    S24/25
  • 危险类别码:
    R36/37/38
  • WGK Germany:
    3
  • 海关编码:
    2827590000
  • 危险品运输编号:
    UN 3260
  • 包装等级:
    III
  • 危险标志:
    GHS05,GHS07
  • 危险性描述:
    H302,H314
  • 危险性防范说明:
    P280,P305 + P351 + P338,P310
  • 危险类别:
    8

SDS

SDS:411184a3826c9a6cb68f0d062851d7b6
查看

制备方法与用途

理化性质

溴化铜为浅灰色或黑色结晶性粉末,具有潮解性;极易溶于;溶于乙醇丙酮吡啶;不溶于苯。

应用

溴化铜可以作为化试剂、氧化试剂以及路易斯酸试剂。

作用机制

溴化铜是一个有效的化试剂,能够作用于多种官能团化合物。例如,在含有羰基的邻位亚甲基发生化反应时,即使存在其他亚甲基(如甾体化合物),它也能识别并选择性地实现羰基邻位的化反应。

用途
  • 照相增感剂:用于增强底片对光线的敏感度。
  • 有机合成中用作化剂:在化学合成过程中提供必要的溴原子
  • 蒸气激光器:置于导管中的溴化氢与熔融状态下的在放电条件下反应生成溴化铜蒸汽,这种激光能产生黄色或绿色光线,在皮肤科领域有应用。
中溶解度 (g/100ml)

不同温度(℃)时每100毫升中可溶解的克数如下:

  • 0℃:107 g
  • 10℃:116 g
  • 20℃:126 g
  • 30℃:128 g
  • 40℃:131 g
危险性

溴化铜有毒,不可食用。长期接触或吸入会对人体的中枢神经系统、大脑、眼睛、肝脏和肾脏造成不良影响,并刺激皮肤及呼吸道。

用途 生产方法
  1. 将按反应式计量的比例氧化铜溶解于热(避免煮沸)的氢溴酸中,经玻璃过滤器过滤后立即置于硫酸上进行真空浓缩,以使目标产物固化。

反应信息

点击查看最新优质反应信息

文献信息

  • Diamine derivatives
    申请人:Ohta Toshiharu
    公开号:US20050020645A1
    公开(公告)日:2005-01-27
    A compound represented by the general formula (1): Q 1 -Q 2 -T 0 -N(R 1 )-Q 3 -N(R 2 )-T 1 -Q 4 (1) wherein R 1 and R 2 are hydrogen atoms or the like; Q 1 is a saturated or unsaturated, 5- or 6-membered cyclic hydrocarbon group which may be substituted, or the like; Q 2 is a single bond or the like; Q 3 is a group in which Q 5 is an alkylene group having 1 to 8 carbon atoms, or the like; and T 0 and T 1 are carbonyl groups or the like; a salt thereof, a solvate thereof, or an N-oxide thereof. The compound is useful as an agent for preventing and/or treating cerebral infarction, cerebral embolism, myocardial infarction, angina pectoris, pulmonary infarction, pulmonary embolism, Buerger's disease, deep venous thrombosis, disseminated intravascular coagulation syndrome, thrombus formation after valve or joint replacement, thrombus formation and reocclusion after angioplasty, systemic inflammatory response syndrome (SIRS), multiple organ dysfunction syndrome (MODS), thrombus formation during extracorporeal circulation, or blood clotting upon blood drawing.
    通用式(1)表示的化合物: Q1-Q2-T0-N(R1)-Q3-N(R2)-T1-Q4(1) 其中R1和R2是氢原子或类似物;Q1是饱和或不饱和的、5-或6-成员环烃基,可以被取代,或类似物;Q2是单键或类似物;Q3是一个基团,其中Q5是具有1至8个碳原子的烷基基团,或类似物;T0和T1是羰基团或类似物;其盐、溶剂合物或N-氧化物。 该化合物可用作预防和/或治疗脑梗死、脑栓塞、心肌梗死、心绞痛、肺梗死、肺栓塞、布尔格病、深静脉血栓形成、弥散性血管内凝血综合征、瓣膜或关节置换后的血栓形成、血管成形术后的血栓形成和再闭塞、全身性炎症反应综合征(SIRS)、多器官功能障碍综合征(MODS)、体外循环期间的血栓形成,或抽血时的血液凝结。
  • Anthranilonitrile derivatives as useful agents for promoting growth,
    申请人:American Cyanamid Company
    公开号:US04863959A1
    公开(公告)日:1989-09-05
    There are provided novel anthranilonitrile derivatives and related compounds which are useful for promoting growth, improving feed efficiency and for increasing the lean meat to fat ratio of warm-blooded animals.
    提供了新颖的基衍生物和相关化合物,可用于促进生长,提高饲料利用率,以及增加温血动物的瘦肉与脂肪比例。
  • N-acylamino acid amide compounds and intermediates for preparation thereof
    申请人:Ube Industries, Ltd.
    公开号:US06265418B1
    公开(公告)日:2001-07-24
    The present invention discloses the compound represented by the formula (I): wherein A represents the following formula (a-1) or the following formula (a-2): B represents the following formula (b): (wherein the symbols are each as defined in the specification) or a pharmaceutically acceptable salts thereof, and intermediates for the preparation thereof, which have excellent platelet aggregation inhibitory activity and other properties and useful as prophylactic or therapeutic agents for diseases associated with a fibrinogen receptor, thrombosis, infarction and the like.
    本发明公开了以下公式(I)所表示的化合物: 其中A代表以下公式(a-1)或以下公式(a-2): B代表以下公式(b): (其中符号如规范中所定义)或其药学上可接受的盐,以及用于制备其的中间体,具有优异的血小板聚集抑制活性和其他性质,并且可用作与纤维蛋白原受体、血栓形成、梗塞等疾病相关的预防或治疗剂。
  • Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as
    申请人:Pfizer Inc.
    公开号:US06071935A1
    公开(公告)日:2000-06-06
    The present invention relates to compounds of the formula ##STR1## wherein R.sub.1, R.sub.2, R.sub.3 and R.sub.4 are as defined herein. The invention also relates to pharmaceutical compositions containing the compounds of formula I and to methods of inhibiting abnormal cell growth, including cancer, in a mammal by administering the compounds of formula I to said mammal.
    本发明涉及以下式的化合物##STR1##其中R.sub.1、R.sub.2、R.sub.3和R.sub.4如本文所定义。该发明还涉及含有式I化合物的药物组合物,以及通过向哺乳动物施用式I化合物来抑制异常细胞生长,包括癌症的方法。
  • 2-heterocyclic-5-hydroxy-1,3-pyrimidines useful as antiinflammatory
    申请人:Warner-Lambert Company
    公开号:US05240929A1
    公开(公告)日:1993-08-31
    The present invention is novel compounds which are 2-heterocyclic-4,6-ditertiarybutyl-5-hydroxy-1,3-pyrimidines, where heterocyclic is selected from imidazole, thiazole, and oxazole, and pharmaceutically acceptable additional salts, bases, and base salts thereof, pharmaceutical compositions and methods of use therefor. The invention compounds are found to have activity as inhibitors of 5-lipoxygenase and/or cyclooxygenase providing treatment of, for example, preferably inflammation.
    本发明为新型化合物,其为2-杂环-4,6-二叔丁基-5-羟基-1,3-嘧啶,其中杂环选自咪唑噻唑恶唑,以及药物可接受的额外盐、碱和碱盐,药物组合物及其用途。发明化合物被发现具有作为5-脂氧合酶和/或环氧合酶抑制剂的活动性,例如,可用于治疗炎症。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台